Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

[Public-private partnerships to address innovation stakes of both industrialized and limited income countries].

Bonneville M.

Med Sci (Paris). 2018 Oct;34(10):763-764. doi: 10.1051/medsci/2018211. Epub 2018 Nov 19. French. No abstract available.

PMID:
30451662
2.

Outcome in patients converting to psychosis following a treated clinical high risk state.

Malla A, de Bonneville M, Shah J, Jordan G, Pruessner M, Faridi K, Rabinovitch M, Iyer SN, Joober R.

Early Interv Psychiatry. 2018 Aug;12(4):715-719. doi: 10.1111/eip.12431. Epub 2017 Jun 14.

PMID:
28613411
3.

The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.

Peigné CM, Léger A, Gesnel MC, Konczak F, Olive D, Bonneville M, Breathnach R, Scotet E.

J Immunol. 2017 Jun 1;198(11):4228-4234. doi: 10.4049/jimmunol.1601910. Epub 2017 May 1.

4.

Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.

Marlin R, Pappalardo A, Kaminski H, Willcox CR, Pitard V, Netzer S, Khairallah C, Lomenech AM, Harly C, Bonneville M, Moreau JF, Scotet E, Willcox BE, Faustin B, Déchanet-Merville J.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3163-3168. doi: 10.1073/pnas.1621052114. Epub 2017 Mar 7.

5.

Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?

Doré J, Multon MC, Béhier JM; les participants à la table ronde 2 des Ateliers de Giens XXXII, Affagard H, Andremont A, Barthélémy P, Batista R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier MP, Cordaillat-Simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-Marche E, Martin FP, Petiteau D.

Therapie. 2017 Feb;72(1):1-19. doi: 10.1016/j.therap.2017.01.001. Epub 2017 Jan 11. French. No abstract available.

PMID:
28214070
6.

Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation.

Rettman P, Willem C, Volteau C, Legrand N, Chevallier P, Lodé L, Esbelin J, Cesbron A, Bonneville M, Moreau P, Senitzer D, Retière C, Gagne K.

Transplantation. 2017 Sep;101(9):2092-2101. doi: 10.1097/TP.0000000000001545.

PMID:
27798515
7.

Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.

Jarry U, Chauvin C, Joalland N, Léger A, Minault S, Robard M, Bonneville M, Oliver L, Vallette FM, Vié H, Pecqueur C, Scotet E.

Oncoimmunology. 2016 Mar 30;5(6):e1168554. doi: 10.1080/2162402X.2016.1168554. eCollection 2016 Jun.

8.

Role of the MHC restriction during maturation of antigen-specific human T cells in the thymus.

Hesnard L, Legoux F, Gautreau L, Moyon M, Baron O, Devilder MC, Bonneville M, Saulquin X.

Eur J Immunol. 2016 Mar;46(3):560-9. doi: 10.1002/eji.201545951. Epub 2015 Dec 22. Erratum in: Eur J Immunol. 2017 Feb;47(2):419.

9.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC.

Oncoimmunology. 2015 Feb 25;4(4):e998538. eCollection 2015 Apr.

10.

Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer.

Rigaud J, Leger A, Devilder MC, Bouchot O, Bonneville M, Scotet E.

Clin Genitourin Cancer. 2015 Aug;13(4):e209-e215. doi: 10.1016/j.clgc.2015.01.005. Epub 2015 Jan 21.

PMID:
25735197
11.

Chicago 2014--30 years of γδ T cells.

Bonneville M, Chen ZW, Déchanet-Merville J, Eberl M, Fournié JJ, Jameson JM, Lopez RD, Massaia M, Silva-Santos B.

Cell Immunol. 2015 Jul;296(1):3-9. doi: 10.1016/j.cellimm.2014.11.001. Epub 2014 Nov 8.

12.

Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.

Reiser JB, Legoux F, Gras S, Trudel E, Chouquet A, Léger A, Le Gorrec M, Machillot P, Bonneville M, Saulquin X, Housset D.

J Immunol. 2014 Dec 15;193(12):5816-26. doi: 10.4049/jimmunol.1303084. Epub 2014 Nov 12.

13.

Targeted activation of human Vγ9Vδ2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease.

Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, Hu H, Lam KT, Chan GC, Yang Y, Chen H, Tsao GS, Bonneville M, Lau YL, Tu W.

Cancer Cell. 2014 Oct 13;26(4):565-76. doi: 10.1016/j.ccr.2014.07.026. Epub 2014 Sep 11.

14.

CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.

Schneiders FL, Prodöhl J, Ruben JM, O'Toole T, Scheper RJ, Bonneville M, Scotet E, Verheul HM, de Gruijl TD, van der Vliet HJ.

Cancer Immunol Res. 2014 Aug;2(8):732-40. doi: 10.1158/2326-6066.CIR-13-0167. Epub 2014 Apr 21.

15.

The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.

Sandstrom A, Peigné CM, Léger A, Crooks JE, Konczak F, Gesnel MC, Breathnach R, Bonneville M, Scotet E, Adams EJ.

Immunity. 2014 Apr 17;40(4):490-500. doi: 10.1016/j.immuni.2014.03.003. Epub 2014 Apr 3.

16.

γδ T cells: first line of defense and beyond.

Chien YH, Meyer C, Bonneville M.

Annu Rev Immunol. 2014;32:121-55. doi: 10.1146/annurev-immunol-032713-120216. Epub 2014 Jan 2. Review.

PMID:
24387714
17.

Characterization of the human CD4(+) T-cell repertoire specific for major histocompatibility class I-restricted antigens.

Legoux F, Gautreau L, Hesnard L, Leger A, Moyon M, Devilder MC, Bonneville M, Saulquin X.

Eur J Immunol. 2013 Dec;43(12):3244-53. doi: 10.1002/eji.201343726. Epub 2013 Oct 21.

18.

Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.

Santolaria T, Robard M, Léger A, Catros V, Bonneville M, Scotet E.

J Immunol. 2013 Aug 15;191(4):1993-2000. doi: 10.4049/jimmunol.1300255. Epub 2013 Jul 8.

19.

Review article: antitumoural immunity in colorectal cancer - current and potential future implications in clinical practice.

Koudougou C, Bonneville M, Matysiak-Budnik T, Touchefeu Y.

Aliment Pharmacol Ther. 2013 Jul;38(1):3-15. doi: 10.1111/apt.12337. Epub 2013 May 20. Review.

20.

Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk.

Ni M, Martire D, Scotet E, Bonneville M, Sanchez F, Lafont V.

PLoS One. 2012;7(8):e43613. doi: 10.1371/journal.pone.0043613. Epub 2012 Aug 22.

21.

Semaphorins: new cues for skin healing by γδ T cells.

Bonneville M.

Immunity. 2012 Aug 24;37(2):194-6. doi: 10.1016/j.immuni.2012.08.003.

22.

The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies.

Palakodeti A, Sandstrom A, Sundaresan L, Harly C, Nedellec S, Olive D, Scotet E, Bonneville M, Adams EJ.

J Biol Chem. 2012 Sep 21;287(39):32780-90. Epub 2012 Jul 30.

23.

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Harly C, Guillaume Y, Nedellec S, Peigné CM, Mönkkönen H, Mönkkönen J, Li J, Kuball J, Adams EJ, Netzer S, Déchanet-Merville J, Léger A, Herrmann T, Breathnach R, Olive D, Bonneville M, Scotet E.

Blood. 2012 Sep 13;120(11):2269-79. doi: 10.1182/blood-2012-05-430470. Epub 2012 Jul 5.

24.

Thymic signatures of tailored peripheral functions.

Bonneville M.

Nat Immunol. 2012 Apr 18;13(5):431-3. doi: 10.1038/ni.2287. No abstract available.

PMID:
22513325
25.

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

Schneiders FL, de Bruin RC, Santegoets SJ, Bonneville M, Scotet E, Scheper RJ, Verheul HM, de Gruijl TD, van der Vliet HJ.

Clin Immunol. 2012 Feb;142(2):194-200. doi: 10.1016/j.clim.2011.10.006. Epub 2011 Nov 4.

PMID:
22122798
26.

Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells.

Mbitikon-Kobo FM, Bonneville M, Sekaly RP, Trautmann L.

J Immunol Methods. 2012 Jan 31;375(1-2):252-7. doi: 10.1016/j.jim.2011.09.008. Epub 2011 Oct 5.

PMID:
21996428
27.

Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.

Harly C, Peyrat MA, Netzer S, Déchanet-Merville J, Bonneville M, Scotet E.

Blood. 2011 Mar 10;117(10):2864-73. doi: 10.1182/blood-2010-09-309781. Epub 2011 Jan 13.

28.

Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.

Morice A, Charreau B, Neveu B, Brouard S, Soulillou JP, Bonneville M, Houssaint E, Degauque N.

PLoS One. 2010 Aug 12;5(8):e12120. doi: 10.1371/journal.pone.0012120.

29.

Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Bonneville M, O'Brien RL, Born WK.

Nat Rev Immunol. 2010 Jul;10(7):467-78. doi: 10.1038/nri2781. Epub 2010 Jun 11. Review.

PMID:
20539306
30.

NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.

Nedellec S, Sabourin C, Bonneville M, Scotet E.

J Immunol. 2010 Jul 1;185(1):55-63. doi: 10.4049/jimmunol.1000373. Epub 2010 May 28.

31.

Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans.

Legoux F, Debeaupuis E, Echasserieau K, De La Salle H, Saulquin X, Bonneville M.

J Immunol. 2010 Jun 15;184(12):6731-8. doi: 10.4049/jimmunol.1000295. Epub 2010 May 14.

32.

Human Vgamma9Vdelta2 T cells: from signals to functions.

Nedellec S, Bonneville M, Scotet E.

Semin Immunol. 2010 Aug;22(4):199-206. doi: 10.1016/j.smim.2010.04.004. Epub 2010 May 5. Review.

PMID:
20447835
33.

Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen.

Reiser JB, Legoux F, Machillot P, Debeaupuis E, Le Moullac-Vaydie B, Chouquet A, Saulquin X, Bonneville M, Housset D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Nov 1;65(Pt 11):1157-61. doi: 10.1107/S1744309109037890. Epub 2009 Oct 30.

34.

Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.

David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, Bonneville M, Folléa G, Bignon JD, Retière C.

Immunology. 2009 Oct;128(2):172-84. doi: 10.1111/j.1365-2567.2009.03085.x.

35.

Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.

Devilder MC, Allain S, Dousset C, Bonneville M, Scotet E.

J Immunol. 2009 Sep 15;183(6):3625-33. doi: 10.4049/jimmunol.0901571. Epub 2009 Aug 26.

36.

Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?

Deknuydt F, Scotet E, Bonneville M.

Immunol Lett. 2009 Dec 2;127(1):8-12. doi: 10.1016/j.imlet.2009.08.003. Epub 2009 Aug 12. Review.

PMID:
19682496
37.

Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate.

Trompezinski S, Bonneville M, Pernet I, Denis A, Schmitt D, Viac J.

Arch Dermatol Res. 2010 Apr;302(3):183-9. doi: 10.1007/s00403-009-0979-x. Epub 2009 Jul 14.

PMID:
19597830
38.

Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.

Lacône V, Hunault J, Pipelier M, Blot V, Lecourt T, Rocher J, Turcot-Dubois AL, Marionneau S, Douillard JY, Clément M, Le Pendu J, Bonneville M, Micouin L, Dubreuil D.

J Med Chem. 2009 Aug 13;52(15):4960-3. doi: 10.1021/jm900290r.

PMID:
19580320
39.

Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.

Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, Kissenpfennig A, Legoux F, Chouquet A, Le Gorrec M, Machillot P, Neveu B, Thielens N, Malissen B, Bonneville M, Housset D.

J Immunol. 2009 Jul 1;183(1):430-7. doi: 10.4049/jimmunol.0900556.

40.

IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.

Thedrez A, Harly C, Morice A, Salot S, Bonneville M, Scotet E.

J Immunol. 2009 Mar 15;182(6):3423-31. doi: 10.4049/jimmunol.0803068.

41.

Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.

Neveu B, Debeaupuis E, Echasserieau K, le Moullac-Vaidye B, Gassin M, Jegou L, Decalf J, Albert M, Ferry N, Gournay J, Houssaint E, Bonneville M, Saulquin X.

Hepatology. 2008 Sep;48(3):713-22. doi: 10.1002/hep.22379.

PMID:
18712791
42.

gammadelta T cell selection: is anyone useless?

Bonneville M.

Immunity. 2008 Jul 18;29(1):3-5. doi: 10.1016/j.immuni.2008.06.007.

43.

Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.

Scotet E, Nedellec S, Devilder MC, Allain S, Bonneville M.

Front Biosci. 2008 May 1;13:6872-85. Review.

PMID:
18508701
44.

Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor.

Gakamsky DM, Lewitzki E, Grell E, Saulquin X, Malissen B, Montero-Julian F, Bonneville M, Pecht I.

Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16639-44. Epub 2007 Oct 5.

45.

Laminaria ochroleuca extract reduces skin inflammation.

Bonneville M, Saint-Mezard P, Benetiere J, Hennino A, Pernet I, Denis A, Nicolas JF.

J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1124-5. No abstract available.

PMID:
17714147
46.

CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.

Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, Casorati G.

Blood. 2007 Jul 1;110(1):251-8. Epub 2007 Mar 15.

47.

Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?

Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain-Maillet S, Fournié JJ, Scotet E, Bonneville M.

Immunol Rev. 2007 Feb;215:123-35. Review.

PMID:
17291284
48.

Skin contact irritation conditions the development and severity of allergic contact dermatitis.

Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, Denis A, Nicolas JF, Hennino A.

J Invest Dermatol. 2007 Jun;127(6):1430-5. Epub 2007 Feb 1.

49.

Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.

Trichet V, Benezech C, Dousset C, Gesnel MC, Bonneville M, Breathnach R.

J Immunol. 2006 Nov 1;177(9):6129-36.

50.

CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production.

Caccamo N, Battistini L, Bonneville M, Poccia F, Fournié JJ, Meraviglia S, Borsellino G, Kroczek RA, La Mendola C, Scotet E, Dieli F, Salerno A.

J Immunol. 2006 Oct 15;177(8):5290-5.

Supplemental Content

Loading ...
Support Center